Fasoracetam pauka mea hana CAS No.: 110958-19-5 99% maemae min. no nā mea hoʻohui
Video Huahana
Nā Kūlana Huahana
| inoa huahana | Fasoracetam |
| inoa ʻē aʻe | FASORACETAM; (5R) -5- (piperidine-1-carbonyl) -2-pyrrolidone; (5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one; (5R) -5-piperidin-1-ylcarbonylpyrrolidin-2-one |
| CAS No. | 110958-19-5 |
| ʻAno molekala | C10H16N2O2 |
| Kaumaha molekula | 196.25 |
| Maemae | 99.0% |
| Ka nana aku | ʻO ka pauka kristal keʻokeʻo |
| Hoʻopili | 1 kg / ʻeke 25kg / pahu |
| Palapala noi | Nootropic |
Hoʻolauna huahana
ʻO Fasoracetam, kahi pūhui nootropic i kūkulu mua ʻia ma Iapana. Hoʻokaʻawale ia i nā ʻano like me nā racemates e like me ka piracetam, akā hōʻike i nā hiʻohiʻona hana kūʻokoʻa. Manaʻo ʻia ʻo Fasoracetam e hoʻololi i nā hopena o nā neurotransmitters like ʻole i ka lolo, me ka GABA, glutamatergic, a me nā ʻōnaehana cholinergic. Ma ka hoʻopili ʻana i ka hoʻokuʻu ʻana a me ka lawe ʻana o kēia mau neurotransmitters, hiki i ka fasoracetam ke hoʻomaikaʻi i nā hana cognitive e like me ka nānā ʻana, ka hoʻohui ʻana i ka hoʻomanaʻo, a me ka hoʻoili ʻike. Hōʻike ka noiʻi a me nā hōʻike anecdotal e hiki i ka fasoracetam ke hāʻawi i nā pono cognitive he nui. ʻO kekahi o kāna mau hopena nui, ʻo ia ka hoʻonui ʻana i ka noʻonoʻo a me ka lōʻihi o ka nānā ʻana, e lilo ana ia i mea kōkua kūpono no ka poʻe e loaʻa ana i ka maʻi deficit deficit a i ʻole attention deficit hyperactivity disorder (ADD/ADHD). Ua hōʻike nā haʻawina mua i nā hopena hoʻohiki, e hōʻike ana i ka hiki o fasoracetam ke hoʻomaikaʻi i ka nānā, hoʻemi i ka impulsivity a hoʻonui i ka mana cognitive. Eia kekahi, hōʻike nā haʻawina holoholona e hoʻonui ʻo Fasoracetam i ka potentiation lōʻihi, kahi kaʻina e pili ana i ka hoʻomanaʻo hoʻomanaʻo a me ka synaptic plasticity.
Hiʻona
(1) Maʻemaʻe kiʻekiʻe: Hiki i ka Fasoracetam ke loaʻa nā huahana maʻemaʻe kiʻekiʻe ma o ka hoʻomaʻemaʻe ʻana i nā kaʻina hana. ʻO ka maʻemaʻe kiʻekiʻe, ʻoi aku ka maikaʻi o ka bioavailability a me ka liʻiliʻi o nā hopena ʻino.
(2) Palekana: Ua hōʻike ʻia nā haʻawina e ʻae maikaʻi ʻia ka fasoracetam a ʻaʻole hōʻike i nā hopena ʻaoʻao koʻikoʻi ke hoʻohana ʻia i loko o nā kau i ʻōlelo ʻia.
(3) Paʻa: He kūpaʻa maikaʻi ka Fasoracetam a hiki ke mālama i kāna hana a me ka hopena ma lalo o nā kaiapuni likeʻole a me nā kūlana mālama.
Nā noi
Ua puka mai ʻo Fasoracetam ma ke ʻano he pūhui hoihoi me ka hiki ke hoʻonui i nā mana cognitive, ʻoi aku ka hoʻomanaʻo, ka nānā ʻana, a me ke aʻo ʻana, a hiki ke hoʻohana ʻia ma ke ʻano he meaʻai meaʻai. Hana kēia huahana i mea hoʻonui hoʻomanaʻo ma o ka hoʻoulu ʻana i ka metabolic glutamate receptors. Ma ke kahua olaola, hoʻohana pū ʻia ʻo Fasoracetam ma ke ʻano he mea hoʻopale koho e aʻo i nā kaʻina hana olaola e like me ka hōʻailona cell a me ka apoptosis.
